XK469 in Treating Patients With Advanced Solid Tumors
NCT00028548
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
R(+)XK469
Sponsor
Barbara Ann Karmanos Cancer Institute
Collaborators
[object Object]